| # | Drug | Count |
|---|---|---|
| 0 | ANASTROZOLE | 2 |
| 1 | CAPECITABINE | 2 |
| 2 | METHOTREXATE | 2 |
| 3 | METHOTREXATE SODIUM | 2 |
| 4 | ADALIMUMAB | 1 |
| 5 | AFATINIB | 1 |
| 6 | ASPIRIN | 1 |
| 7 | ASPIRIN 325 MG | 1 |
| 8 | ASPIRIN 81 MG | 1 |
| 9 | BEVACIZUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIV-AFLIBERCEPT | 1 | 0.0008 |
| 1 | AFATINIB | 1 | 0.0002 |
| 2 | FONDAPARINUX SODIUM | 1 | 0.0001 |
| 3 | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | 1 | 0.0001 |
| 4 | BUSPIRONE HYDROCHLORIDE | 1 | 0.0001 |
| 5 | OXCARBAZEPINE | 1 | 0.0001 |
| 6 | PANITUMUMAB | 1 | 0.0001 |
| 7 | ANASTROZOLE | 2 | 0.0001 |
| 8 | NIRAPARIB | 1 | 0.0000 |
| 9 | MODAFINIL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 1 | Aromatase Inhibitor [EPC] | 3 | 0.0000 |
| 2 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 3 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 9 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |